Free Trial

Bristol-Myers Squibb 6pt Launched, Drops 3NC1 FRN, Fannie Mae Priced

PIPELINE

$18.5B To price Monday, not including Fannie Mae

  • Date $MM Issuer (Priced *, Launch #
  • 11/09 $7B #Bristol-Myers Squibb 6pt: $1.5B 3NC1 +30, $1B 5Y +35, $1B 7Y +45, $1.25B 10Y +55, $750M 20Y +65, $1.5B 30Y +85. Last multi-tranche jumbo issue from Bristol-Myers: total $19B in 9-parts on May 7, 2019: $750M 1.5Y +20, $1B 2Y +35, $1.5B 3Y fix +45, $500M 3Y FRN L+38, $3.25B 5Y +73, $2.25B 7Y +90, $4B 10Y +105, $2B 20Y +30, $3.75B 30Y +145.
  • 11/09 $4.5B #Morgan Stanley $1.75B 3NC2 +37.5, $2.75B 11.25NC10.25 +85
  • 11/09 $2.5B #Westpac 15NC10 +175, 20Y +125
  • 11/09 $1.2B #Vereit $500M +7Y +165, $700M 12Y +200
  • 11/09 $1.1B #Republic Srvcs $350M 5Y +45, $750M 11Y +80
  • 11/09 $1B #Caterpillar 5Y +38, (issued $2B each on May 12, Jan 9)
  • 11/09 $600M #Entergy LA $300M 10Y +70, $300M Tap 2.9% +95
  • 11/09 $600M #Consolidated Edison 40Y +128
  • 11/09 $4B *Fannie Mae 5Y +13.5

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.